Use of Home-Based Telemedicine to Improve Healthcare Utilization and Outcomes in Pediatric Patients With Poorly Controlled Type 1 Diabetes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 59
- 试验地点
- 2
- 主要终点
- Improvement in A1C Levels
研究概览
简要总结
At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk pediatric cohort with T1D.
Aim 1. To test the hypothesis that home-based telemedicine is a feasible and acceptable method of care delivery for patients with poorly controlled type 1 diabetes (T1D) currently cared for at the University of California, Davis (UCD) Pediatric Endocrinology clinic. Specifically:
A) Patients and families choose to participate in telemedicine visits as a supplement to in-person care; B) Patients and families can utilize secure, internet-based platforms to upload and share glucose meter data and to establish an audio-video connection with a diabetes specialist in their home settings; C) Patients and families are satisfied with the experience of home-based telemedicine and would choose to receive future diabetes care via this modality.
Aim 2. To test the hypothesis that using home-based telemedicine, these patients can complete more frequent visits with a diabetes specialist than they previously completed via office visits alone.
Aim 3. To test the hypothesis that increased contact with a diabetes specialist via home-based telemedicine will lead to significant improvement in glycemic control for these patients.
Aim 4. To evaluate the effects of increased contact with a diabetes specialist via home-based telemedicine on high-cost health care utilization - specifically emergency department (ED) visits and diabetes-related hospitalizations.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 1-17 years
- •known diagnosis of T1D
- •>1 prior visit to the UC Davis Pediatric Endocrinology clinic (to avoid enrolling newly diagnosed patients)
- •suboptimal glycemic control, defined as most recent hemoglobin A1C level of >8%
- •access to the internet via a device with video and audio capability (e.g. computer, tablet, mobile phone)
- •ability to connect their home glucose meter to an internet-capable device via Bluetooth or physical cable for the purpose of data uploading.
排除标准
- •Patients and parents whose primary language is not English
- •Patients who have Western Health Advantage health insurance
结局指标
主要结局
Improvement in A1C Levels
时间窗: 12-months
Investigators will compare the mean pre-study and mean post-study A1C levels
次要结局
- Increased visit frequency(24-months)
- Impact on high-cost health care utilization(24-months)
- Acceptability of home-based telemedicine(12-months)
- Feasibility of home-based telemedicine(12-months)